Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-04-18 @ 5:08 PM
Study NCT ID:
NCT05482295
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-06
First Post:
2022-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Sponsor:
PT Bio Farma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HepB 0322
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |